Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total		Common Stock	Additional Paid-in Capital	Unearned Employee Stock Ownership Plan Shares	Retained Earnings	Accumulated Other Comprehensive Income (Loss), net
Balance at beginning of period at Dec. 31, 2018	$ 117,476		$ 66,008	$ 36,972	$ (1,734)	$ 17,557	$ (1,327)
Balance at beginning of period, Shares at Dec. 31, 2018			13,201,682
Net (loss) income	1,492					1,492
Other comprehensive income, net	806						806
Stock options exercised, net	9		$ 26	(17)
Stock options exercised, Shares			5,173
Director and executive stock grant	6		$ 4	2
Director and executive stock grant, Shares			762
Restricted stock awards			$ 530	(530)
Restricted stock awards,shares			105,920
ESOP collateral release	37				37
Share-based compensation expense	66			66
Cumulative effect adjustment of adoption of accounting principle	45					45
Balance at end of period at Mar. 31, 2019	119,937		$ 66,568	36,493	(1,697)	19,094	(521)
Balance at end of period, Shares at Mar. 31, 2019			13,313,537
Balance at beginning of period at Dec. 31, 2019	$ 126,185	[1]	$ 66,309	36,658	(1,525)	24,660	83
Balance at beginning of period, Shares at Dec. 31, 2019	13,261,801	[1]	13,261,801
Net (loss) income	$ (14)					(14)
Other comprehensive income, net	866						866
Stock options exercised, net	81		$ 77	4
Stock options exercised, Shares			15,514
Director and executive stock grant	105		$ 59	46
Director and executive stock grant, Shares			11,734
Restricted stock awards			$ 305	(305)
Restricted stock awards,shares			61,020
Shares repurchased pursuant to ESOP	$ (25)		$ (16)	(9)
Shares repurchased pursuant to ESOP,shares	0		(3,280)
ESOP collateral release	$ 62				62
Share-based compensation expense	142			142
Balance at end of period at Mar. 31, 2020	$ 127,402		$ 66,734	$ 36,536	$ (1,463)	$ 24,646	$ 949
Balance at end of period, Shares at Mar. 31, 2020	13,346,789		13,346,789

[1] Derived from audited December 31, 2019 Consolidated Financial Statements.